Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.49 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
| ▸ | MMP8 | P22894 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5168366 | 1.00 | ALDH1A1 (0.53) | ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL5169494 | 1.00 | ALDH1A1 (0.53) | ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL28656889 | 0.98 | ALDH1A1 (0.52) | ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL7924569 | 0.95 | KMT2A (0.49) | ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL12437213 | 0.90 | PPARG (0.47) | ALDH1A1CYP1A2CYP2C9CYP2C19TSHR | |
| SCHEMBL1968068 | 0.90 | PPARG (0.47) | ALDH1A1CYP1A2CYP2C9CYP2C19TSHR | |
| SCHEMBL138281 | 0.85 | KMT2A (0.56) | ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL138280 | 0.85 | KMT2A (0.56) | ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL27757196 | 0.85 | KMT2A (0.56) | ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL1706675 | 0.85 | KMT2A (0.56) | ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109796368-B | Synthesis method of N' - [ (2S,3S) -2- (benzyloxy) pentan-3-yl ] formylhydrazine | 浙江大学宁波理工学院 | 2021-11-02 | — | — | CN | claimed |
| CN-109651187-B | Synthesis method of (S) -N' - (2-benzyloxypropylene) formylhydrazine | 宁波新极新材料科技有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-109796368-A | A kind of synthetic method of N '-[(2S, 3S) -2-(benzyloxy) amyl- 3- yl] formylhydrazine | 浙江大学宁波理工学院 | 2019-05-24 | — | — | CN | claimed |
| CN-109651187-A | The synthetic method of one kind (S)-N '-(2- benzyloxy propylidene) formylhydrazine | 宁波新极新材料科技有限公司 | 2019-04-19 | — | — | CN | claimed |
| CN-109651132-A | The synthetic method of one kind (S) -2- benzyloxy propionic aldehyde | 宁波新凯生物科技有限公司 | 2019-04-19 | — | — | CN | claimed |
| EP-0665858-B1 | PROCESS FOR PREPARING ALIPHATIC POLYESTERS | SHELL INT RESEARCH (NL) | 1998-01-21 | — | — | EP | claimed |
| JP-H08502313-A | — | — | 1996-03-12 | — | — | JP | claimed |
| EP-0665858-A1 | PROCESS FOR PREPARING ALIPHATIC POLYESTERS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1995-08-09 | — | — | EP | claimed |
| US-5378797-A | Process for preparing aliphatic polyesters | SHELL OIL COMPANY (US) | 1995-01-03 | — | — | US | claimed |
| WO-1994009054-A1 | PROCESS FOR PREPARING ALIPHATIC POLYESTERS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1994-04-28 | — | — | WO | claimed |
| WO-2025064681-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | ENTASIS THERAPEUTICS INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| US-12110293-B2 | Substituted triazolo quinoxaline derivatives | Grünenthal GmbH (DE) | 2024-10-08 | — | — | US | disclosed |
| US-11767295-B2 | Isoindole derivative | TIANJIN HEMAY PHARMACEUTICAL CO., LTD. (CN) | 2023-09-26 | — | — | US | disclosed |
| CN-112673009-B | Substituted triazoloquinoxaline derivatives | 格吕伦塔尔有限公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-3823971-B1 | SUBSTITUTED TRIAZOLO QUINOXALINE DERIVATIVES | GRUENENTHAL GMBH (DE) | 2022-07-27 | — | — | EP | disclosed |
| EP-1080062-A1 | PROCESS FOR THE PREPARATION OF 2-HYDROXYALKYL HALOPHENONES | Avecia Limited (GB) | 2001-03-07 | — | — | EP | disclosed |
| US-6051583-A | CARDIOVASCULAR DISORDERS; BRAIN DISORDERS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-04-18 | — | — | US | disclosed |
| WO-1999054272-A1 | PROCESS FOR THE PREPARATION OF 2-HYDROXYALKYL HALOPHENONES | AVECIA LIMITED (GB) | 1999-10-28 | — | — | WO | disclosed |
| EP-0768303-A1 | OPTICALLY ACTIVE QUINOLINECARBOXYLIC ACID DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1997-04-16 | — | — | EP | disclosed |
| US-5266346-A | Extended ester derivatives as low calorie fat mimetics | NABISCO, INC. (US) | 1993-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767295-B2 | Isoindole derivative | COX4I1, ALDH1A2, GDI2 | ALDH1A1 78/4885SLC1A3 2781/4885SLC1A2 1360/4885 |
| US-12110293-B2 | Substituted triazolo quinoxaline derivatives | NR3C1, NR3C2, GRK5 | ALDH1A1 1871/4885SLC1A3 2150/4885SLC1A2 1599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.